COLLEGIUM PHARMACEUTICAL, INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Collegium Pharmaceutical, Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2014 to Q2 2024.
  • Collegium Pharmaceutical, Inc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $19.6M, a 50.7% increase year-over-year.
  • Collegium Pharmaceutical, Inc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was $99.9M.
  • Collegium Pharmaceutical, Inc annual Net Income (Loss) Attributable to Parent for 2023 was $48.2M.
  • Collegium Pharmaceutical, Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$25M, a 135% decline from 2021.
  • Collegium Pharmaceutical, Inc annual Net Income (Loss) Attributable to Parent for 2021 was $71.5M, a 167% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $99.9M $19.6M +$6.6M +50.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $93.3M $27.7M +$45.1M Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-08
Q4 2023 $48.2M $31.9M +$39.1M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $9.02M $20.6M +$20.2M +4415% Jul 1, 2023 Sep 30, 2023 10-K 2024-02-22
Q2 2023 -$11.2M $13M +$18.2M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$29.4M -$17.4M -$4.36M -33.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-08
Q4 2022 -$25M -$7.2M +$17.8M +71.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 -$42.8M $457K -$7.59M -94.3% Jul 1, 2022 Sep 30, 2022 10-K 2024-02-22
Q2 2022 -$35.2M -$5.19M -$78M -107% Apr 1, 2022 Jun 30, 2022 10-K 2024-02-22
Q1 2022 $42.8M -$13.1M -$28.7M -183% Jan 1, 2022 Mar 31, 2022 10-K 2024-02-22
Q4 2021 $71.5M -$25M -$32M -460% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-23
Q3 2021 $104M $8.05M -$3.24M -28.7% Jul 1, 2021 Sep 30, 2021 10-K 2023-02-23
Q2 2021 $107M $72.8M +$64.8M +804% Apr 1, 2021 Jun 30, 2021 10-K 2023-02-23
Q1 2021 $42M $15.7M +$15.2M +3380% Jan 1, 2021 Mar 31, 2021 10-K 2023-02-23
Q4 2020 $26.8M $6.96M +$9.16M Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 $17.6M $11.3M +$17.4M Jul 1, 2020 Sep 30, 2020 10-K 2022-02-24
Q2 2020 $198K $8.06M +$12.8M Apr 1, 2020 Jun 30, 2020 10-K 2022-02-24
Q1 2020 -$12.6M $450K +$10.2M Jan 1, 2020 Mar 31, 2020 10-K 2022-02-24
Q4 2019 -$22.7M -$2.2M -$11.3M -124% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$11.4M -$6.11M +$10.4M +63% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-25
Q2 2019 -$21.8M -$4.71M +$8.35M +63.9% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-25
Q1 2019 -$30.2M -$9.7M +$8.95M +48% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-25
Q4 2018 -$39.1M $9.09M +$26.5M Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 -$65.6M -$16.5M -$3.24M -24.4% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-27
Q2 2018 -$62.4M -$13.1M +$8.06M +38.2% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-27
Q1 2018 -$70.4M -$18.7M +$4.43M +19.2% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-27
Q4 2017 -$74.9M -$17.4M +$10.2M +36.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 -$85M -$13.3M +$13.2M +49.8% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-27
Q2 2017 -$98.2M -$21.1M +$3.4M +13.9% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-27
Q1 2017 -$102M -$23.1M -$7.43M -47.4% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-27
Q4 2016 -$94.2M -$27.6M -$18M -189% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-07
Q3 2016 -$76.1M -$26.4M -$17.1M -182% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-07
Q2 2016 -$59.1M -$24.5M -$19.8M -425% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-07
Q1 2016 -$39.2M -$15.7M -$12M -324% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-07
Q4 2015 -$27.3M -$9.53M -$6.06M -175% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-10
Q3 2015 -$21.2M -$9.36M -$2.81M -42.8% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-10
Q2 2015 -$18.4M -$4.67M -$557K -13.5% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-10
Q1 2015 -$17.8M -$3.69M +$81K +2.15% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-10
Q4 2014 -$17.9M -$3.47M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-18
Q3 2014 -$6.56M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-18
Q2 2014 -$4.12M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-18
Q1 2014 -$3.78M Jan 1, 2014 Mar 31, 2014 10-K 2016-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.